Luxist Web Search

  1. Ads

    related to: sellas life sciences stock forecast model

Search results

  1. Results From The WOW.Com Content Network
  2. SELLAS Life Sciences Group Third Quarter 2022 Earnings ... - AOL

    www.aol.com/news/sellas-life-sciences-group...

    SELLAS Life Sciences Group ( NASDAQ:SLS ) Third Quarter 2022 Results Key Financial Results Net loss: US$7.02m (flat on... SELLAS Life Sciences Group Third Quarter 2022 Earnings: US$0.34 loss per ...

  3. Galena Biopharma - Wikipedia

    en.wikipedia.org/wiki/Galena_Biopharma

    Merger with Sellas Life Sciences. In 2017, Galena Biopharma Inc. announced a merger "with privately-held oncology company Sellas Life Sciences Group Ltd. in an all-stock transaction." The combined company was Sellas Life Science Group. The newly merged companies focused on the development of novel treatments for cancer.

  4. Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In ...

    www.aol.com/news/sellas-ovarian-cancer-candidate...

    SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...

  5. SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To ... - AOL

    www.aol.com/news/sellas-life-sciences-group...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Liminal BioSciences - Wikipedia

    en.wikipedia.org/wiki/Liminal_BioSciences

    Liminal BioSciences' aim to develop best or first-in-class therapies targeting indications with significant unmet needs, where a novel small molecule approach may be better suited using its drug discovery platform, specialized know-how and data-driven development plans. Liminal BioSciences is a development stage biopharmaceutical company ...

  7. Verily - Wikipedia

    en.wikipedia.org/wiki/Verily

    Verily Life Sciences LLC, also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. with restructuring completed on October 2, 2015.

  1. Ads

    related to: sellas life sciences stock forecast model